Search research articles
Contact Us
Filters
Showing results (31-40 of 108) with videos related to
Page
of 11
Sort By:
Diabetes/Metabolism Research and Reviews
|
September 3, 2004
Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes
Mark S Fineman, Larry Z Shen, Kristin Taylor, et al.
Retina (Philadelphia, Pa.)
|
June 26, 2001
Ultrasound biomicroscopic diagnosis of an occult intrascleral foreign body: an unusual case of ocular siderosis
M S Fineman, S Sharma, G K Shah, et al.
Journal of Clinical Pharmacology
|
April 28, 2007
Pharmacokinetics of an oral drug (acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetes
Terrie A Kellmeyer, Nicole C Kesty, Yan Wang, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
January 15, 2000
Changing trends in paintball sport-related ocular injuries
M S Fineman, D H Fischer, J B Jeffers, et al.
Retina (Philadelphia, Pa.)
|
August 14, 2008
Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes
Jason Hsu, Eric Chen, Omesh Gupta, et al.
Frontiers in Sleep
|
April 8, 2024
Forward and Back is Not Enough: Applying Best Practices for Translation of Pediatric Sleep Questionnaires
Darcy A Thompson, Melissa S Fineman, Estefania Miramontes Valdes, et al.
Ophthalmology
|
March 21, 1998
Melanocytomalytic glaucoma in eyes with necrotic iris melanocytoma
M S Fineman, R C Eagle, J A Shields, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 10, 2005
Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes
K Taylor, D Kim, L L Nielsen, et al.
Diabetes, Obesity & Metabolism
|
August 6, 2025
GLY-200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double-blind placebo-controlled trial
Christine L N Bryant, Kevin Colbert, Marcus Hompesch, et al.
Clinical Nuclear Medicine
|
May 1, 1989
Multidisciplinary imaging of Budd-Chiari syndrome
D S Fineman, S D Baran, C J Palestro, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 108) with videos related to
Sort By:
Page
of 11
Diabetes/Metabolism Research and Reviews
|
September 3, 2004
Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes
Mark S Fineman, Larry Z Shen, Kristin Taylor, et al.
Retina (Philadelphia, Pa.)
|
June 26, 2001
Ultrasound biomicroscopic diagnosis of an occult intrascleral foreign body: an unusual case of ocular siderosis
M S Fineman, S Sharma, G K Shah, et al.
Journal of Clinical Pharmacology
|
April 28, 2007
Pharmacokinetics of an oral drug (acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetes
Terrie A Kellmeyer, Nicole C Kesty, Yan Wang, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
January 15, 2000
Changing trends in paintball sport-related ocular injuries
M S Fineman, D H Fischer, J B Jeffers, et al.
Retina (Philadelphia, Pa.)
|
August 14, 2008
Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes
Jason Hsu, Eric Chen, Omesh Gupta, et al.
Frontiers in Sleep
|
April 8, 2024
Forward and Back is Not Enough: Applying Best Practices for Translation of Pediatric Sleep Questionnaires
Darcy A Thompson, Melissa S Fineman, Estefania Miramontes Valdes, et al.
Ophthalmology
|
March 21, 1998
Melanocytomalytic glaucoma in eyes with necrotic iris melanocytoma
M S Fineman, R C Eagle, J A Shields, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 10, 2005
Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes
K Taylor, D Kim, L L Nielsen, et al.
Diabetes, Obesity & Metabolism
|
August 6, 2025
GLY-200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double-blind placebo-controlled trial
Christine L N Bryant, Kevin Colbert, Marcus Hompesch, et al.
Clinical Nuclear Medicine
|
May 1, 1989
Multidisciplinary imaging of Budd-Chiari syndrome
D S Fineman, S D Baran, C J Palestro, et al.
Page
of 11